Detection of a nonerythropoietic erythropoietin, Neuro‐EPO, in blood after intranasal administration in rat

Improved detection methods significantly increase the detection window for EPO microdoses

(2020) Laurent Martin et al.   Drug Testing and Analysis

Combined immuno-purification and detection of recombinant erythropoietins and activin receptor type II-Fc fusion proteins by isoelectric focusing for application in doping control

(2018) Laurent Martin et al.   Drug Testing and Analysis

Pericytes: new EPO-producing cells in the brain

(2016) Peng Ji   BLOOD

New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration

(2016) L. Martin et al.   Drug Testing and Analysis

An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease

(2016) Yamila Rodríguez Cruz et al.   JOURNAL OF ALZHEIMERS DISEASE

Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease

(2015) Juha Punnonen et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimer’s disease

(2013) Tangui Maurice et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil

(2012) Iliana Sosa Teste et al.   TheScientificWorldJOURNAL

The Nasal Route as a Potential Pathway for Delivery of Erythropoietin in the Treatment of Acute Ischemic Stroke in Humans

(2011) Julio Cesar García-Rodríguez et al.   TheScientificWorldJOURNAL

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

SDS-PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control

(2009) Christian Reichel et al.   Drug Testing and Analysis

Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

(2009) Sandra R. Alcalá-Barraza et al.   JOURNAL OF DRUG TARGETING

Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)

(2008) Esther Llop et al.   ANALYTICAL BIOCHEMISTRY